Northern Trust’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.39M Buy
1,152,621
+157,227
+16% +$325K ﹤0.01% 2887
2025
Q1
$2.19M Sell
995,394
-16,362
-2% -$36K ﹤0.01% 2879
2024
Q4
$1.55M Buy
1,011,756
+21,769
+2% +$33.3K ﹤0.01% 3161
2024
Q3
$1.97M Buy
989,987
+55,755
+6% +$111K ﹤0.01% 3013
2024
Q2
$3.27M Sell
934,232
-25,318
-3% -$88.6K ﹤0.01% 2636
2024
Q1
$2.66M Sell
959,550
-28,541
-3% -$79.1K ﹤0.01% 2819
2023
Q4
$1.68M Sell
988,091
-34,514
-3% -$58.7K ﹤0.01% 3090
2023
Q3
$1.05M Buy
1,022,605
+114,032
+13% +$117K ﹤0.01% 3277
2023
Q2
$1.05M Sell
908,573
-75,189
-8% -$87.2K ﹤0.01% 3341
2023
Q1
$1.49M Buy
983,762
+22,472
+2% +$33.9K ﹤0.01% 3073
2022
Q4
$2.4M Sell
961,290
-18,280
-2% -$45.7K ﹤0.01% 2899
2022
Q3
$4.13M Buy
979,570
+24,109
+3% +$102K ﹤0.01% 2611
2022
Q2
$2.67M Buy
955,461
+39,892
+4% +$111K ﹤0.01% 2896
2022
Q1
$5.24M Sell
915,569
-46,121
-5% -$264K ﹤0.01% 2564
2021
Q4
$8.78M Sell
961,690
-4,967
-0.5% -$45.3K ﹤0.01% 2326
2021
Q3
$10.3M Buy
966,657
+4,704
+0.5% +$50.3K ﹤0.01% 2245
2021
Q2
$14.9M Buy
961,953
+4,936
+0.5% +$76.6K ﹤0.01% 2100
2021
Q1
$15.5M Sell
957,017
-42,343
-4% -$686K ﹤0.01% 2008
2020
Q4
$21.2M Sell
999,360
-22,915
-2% -$485K ﹤0.01% 1743
2020
Q3
$15.2M Sell
1,022,275
-58,262
-5% -$863K ﹤0.01% 1832
2020
Q2
$15.9M Buy
1,080,537
+73,895
+7% +$1.09M ﹤0.01% 1796
2020
Q1
$11.8M Buy
1,006,642
+13,290
+1% +$156K ﹤0.01% 1770
2019
Q4
$23.3M Buy
993,352
+79,731
+9% +$1.87M 0.01% 1614
2019
Q3
$16.9M Buy
913,621
+62,586
+7% +$1.16M ﹤0.01% 1809
2019
Q2
$15.8M Buy
851,035
+9,963
+1% +$185K ﹤0.01% 1849
2019
Q1
$20.6M Buy
841,072
+4,537
+0.5% +$111K 0.01% 1661
2018
Q4
$21.7M Sell
836,535
-6,365
-0.8% -$165K 0.01% 1519
2018
Q3
$26.7M Buy
842,900
+80,585
+11% +$2.55M 0.01% 1544
2018
Q2
$29.6M Buy
762,315
+134,247
+21% +$5.22M 0.01% 1454
2018
Q1
$17.3M Buy
628,068
+85,109
+16% +$2.35M ﹤0.01% 1789
2017
Q4
$9.83M Buy
542,959
+9,495
+2% +$172K ﹤0.01% 2198
2017
Q3
$8.61M Sell
533,464
-22,943
-4% -$370K ﹤0.01% 2296
2017
Q2
$7.71M Buy
556,407
+50,354
+10% +$697K ﹤0.01% 2333
2017
Q1
$7.59M Buy
506,053
+139,368
+38% +$2.09M ﹤0.01% 2310
2016
Q4
$4.8M Buy
366,685
+8,420
+2% +$110K ﹤0.01% 2568
2016
Q3
$6.17M Buy
358,265
+1,286
+0.4% +$22.2K ﹤0.01% 2386
2016
Q2
$6.44M Buy
356,979
+15,395
+5% +$278K ﹤0.01% 2303
2016
Q1
$6.49M Sell
341,584
-832
-0.2% -$15.8K ﹤0.01% 2255
2015
Q4
$9.14M Buy
342,416
+15,408
+5% +$411K ﹤0.01% 2079
2015
Q3
$7.98M Buy
327,008
+54,830
+20% +$1.34M ﹤0.01% 2142
2015
Q2
$8.48M Buy
272,178
+10,345
+4% +$322K ﹤0.01% 2168
2015
Q1
$3.81M Buy
261,833
+3,150
+1% +$45.8K ﹤0.01% 2684
2014
Q4
$2.6M Buy
258,683
+24,604
+11% +$247K ﹤0.01% 2932
2014
Q3
$1.95M Buy
234,079
+186,972
+397% +$1.56M ﹤0.01% 3118
2014
Q2
$581K Buy
47,107
+25,654
+120% +$316K ﹤0.01% 3558
2014
Q1
$298K Buy
+21,453
New +$298K ﹤0.01% 3682